Zurich Insurance Group’s Braskem BAK Stock Holding History

Zurich Insurance Group’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,568	Closed	-$38K	–	418
2018 Q4	$38K	Buy	+1,568	New	+$42.5K	﹤0.01%	438

Other funds holding BAK

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Zurich Insurance Group's BAK Position: Q1 2019 in Review

Zurich Insurance Group sold out of Braskem (BAK) in Q1 2019, closing a stake of 1,568 shares — an estimated $38K sold.

Zurich Insurance Group first reported a position in BAK in Q4 2018 and held it in 1 quarter. The position peaked at $38K in Q4 2018. 100 funds tracked by Wall St. Rank hold BAK as of Q1 2019.

Zurich Insurance Group reported no remaining Braskem position as of Q1 2019 after selling out during the quarter.
Zurich Insurance Group sold 1,568 Braskem shares in Q1 2019, an estimated $38K.
Zurich Insurance Group first reported a position in Braskem in Q4 2018 and held it in 1 quarter.
Zurich Insurance Group's Braskem position peaked at $38K in Q4 2018.
100 funds tracked by Wall St. Rank held Braskem as of Q1 2019.

Based on Zurich Insurance Group's 13F filing for Q1 2019, filed 15 May 2019.